InvestorsHub Logo

HDGabor

12/26/19 9:12 PM

#237290 RE: amarininvestor #237289

a-

A settlement would be best for all parties, but the lawyer noted recent developments with one party cut against the possibility of settling...The lawyer concurred with our view a settlement would be in the best interest of Amarin, Dr. Reddy's and Hikma. Moreover, highlighted in the low probability Dr. Reddy's or Hikma win the case, it would allow 5+ generics to enter the market while it is still immature, which would not be ideal for the any party - again incentivizing all parties to settle. However, the lawyer noted Dr. Reddy's has shown a proclivity not to settle over the past 18 months or so. This is in line with conversations with Dr. Reddy's mgmt who has suggested they are not willing to settle. So this remains an issue and it's possible AMRN may have to litigate this to a decision - although the expert feels very confident AMRN will prevail.

Best,
G